NAUMAN MOAZZAM, MD
Hematology & Oncology Physician · LAKEWOOD, CO
Individual Active NPI 1407812043
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 989 | 459,028 | $29,434,357 | $7,097,926 | $5,685,632 |
| 2023 | 993 | 486,283 | $32,139,434 | $7,961,610 | $6,365,498 |
| 2022 | 936 | 452,612 | $27,872,959 | $6,549,509 | $5,242,283 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| Q5110 | Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram | 52,140 | $0 | $0 |
| J9263 | Injection, oxaliplatin, 0.5 mg | 37,100 | $0 | $0 |
| Q5101 | Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram | 32,940 | $0 | $0 |
| J1453 | Injection, fosaprepitant, 1 mg | 28,350 | $0 | $0 |
| J9025 | Injection, azacitidine, 1 mg | 26,995 | $0 | $0 |
| J9271 | Injection, pembrolizumab, 1 mg | 24,900 | $56 | $44 |
| J9299 | Injection, nivolumab, 1 mg | 22,300 | $31 | $25 |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 17,950 | $3 | $2 |
| J0185 | Injection, aprepitant, 1 mg | 17,550 | $2 | $1 |
| J9267 | Injection, paclitaxel, 1 mg | 8,180 | $0 | $0 |
| J1756 | Injection, iron sucrose, 1 mg | 7,800 | $0 | $0 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 7,650 | $0 | $0 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Hematology & Oncology Physician | 207RH0003X | ✓ | 49295 | CO |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Hematology & Oncology Physician providers in Colorado
- NPI 1972587533
- NPI 1851267306
- NPI 1629067012
- NPI 1063617454
- NPI 1851994073
- NPI 1013991736
- NPI 1790818425
- NPI 1285618504
See all Hematology & Oncology Physician providers in Colorado →
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.